These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9788625)

  • 1. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma.
    Varella-Garcia M; Gemmill RM; Rabenhorst SH; Lotto A; Drabkin HA; Archer PA; Franklin WA
    Cancer Res; 1998 Oct; 58(20):4701-7. PubMed ID: 9788625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
    J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
    Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
    Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
    Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.
    Wistuba II; Behrens C; Milchgrub S; Bryant D; Hung J; Minna JD; Gazdar AF
    Oncogene; 1999 Jan; 18(3):643-50. PubMed ID: 9989814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
    Tseng JE; Kemp BL; Khuri FR; Kurie JM; Lee JS; Zhou X; Liu D; Hong WK; Mao L
    Cancer Res; 1999 Oct; 59(19):4798-803. PubMed ID: 10519387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic deletion mapping on chromosome 5 in human carcinomas.
    Wieland I; Böhm M; Arden KC; Ammermüller T; Bogatz S; Viars CS; Rajewsky MF
    Oncogene; 1996 Jan; 12(1):97-102. PubMed ID: 8552404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitarget FISH and LOH analyses at chromosome 3p in non-small cell lung cancer and adjacent bronchial epithelium.
    Woenckhaus M; Grepmeier U; Wild PJ; Merk J; Pfeifer M; Woenckhaus U; Stoelcker B; Blaszyk H; Hofstaedter F; Dietmaier W; Hartmann A
    Am J Clin Pathol; 2005 May; 123(5):752-61. PubMed ID: 15981815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Numerical abnormalities of chromosome 9 and p16CDKN2A gene deletion detected by FISH in non-small cell lung cancer.
    Panani AD; Maliaga K; Babanaraki A; Bellenis I
    Anticancer Res; 2009 Nov; 29(11):4483-7. PubMed ID: 20032395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
    Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
    J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis.
    Uematsu K; Yoshimura A; Gemma A; Mochimaru H; Hosoya Y; Kunugi S; Matsuda K; Seike M; Kurimoto F; Takenaka K; Koizumi K; Fukuda Y; Tanaka S; Chin K; Jablons DM; Kudoh S
    Cancer Res; 2001 Dec; 61(23):8527-33. PubMed ID: 11731438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
    Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis.
    Kraggerud SM; Aman P; Holm R; Stenwig AE; Fosså SD; Nesland JM; Lothe RA
    Cancer Res; 2002 Jan; 62(2):512-7. PubMed ID: 11809703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
    Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
    Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma.
    Tomizawa Y; Nakajima T; Kohno T; Saito R; Yamaguchi N; Yokota J
    Cancer Res; 1998 Dec; 58(23):5478-83. PubMed ID: 9850082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.
    Shiseki M; Kohno T; Nishikawa R; Sameshima Y; Mizoguchi H; Yokota J
    Cancer Res; 1994 Nov; 54(21):5643-8. PubMed ID: 7923210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.